एपीए उद्धरण

Pawlyn, C., Bright, M. D., Buros, A. F., Stein, C. K., Walters, Z., Aronson, L. I., . . . Davies, F. E. (2017). Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control. Blood Cancer J.

शिकागो स्टाइल उद्धरण

Pawlyn, C., et al. "Overexpression of EZH2 in Multiple Myeloma Is Associated With Poor Prognosis and Dysregulation of Cell Cycle Control." Blood Cancer J 2017.

एमएलए उद्धरण

Pawlyn, C., et al. "Overexpression of EZH2 in Multiple Myeloma Is Associated With Poor Prognosis and Dysregulation of Cell Cycle Control." Blood Cancer J 2017.